From gut to depression - The role of intestinal barrier dysfunction and activation of the immune system in the inflammatory hypothesis of depression;Od jelit do depresji - Rola zaburzeń cia̧głości bariery jelitowej i nastȩpcza aktywacja układu immunologicznego w zapalnej hipotezie depresji

Neuropsychiatria i Neuropsychologia

Volumn 7, Issue 2, 2012, Pages 76-84

  Rudzki, Leszek ^a   Frank, Monika ^b   Szulc, Agata ^b   Gałȩcka, Mirosława ^b   Szachta, Patrycja ^b   Barwinek, Dominika ^c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Instytut Mikroekologii   (Poland)

^c Wydział Chemiczny Politechniki ^*  (Poland)

Author keywords

Depression; IgG dependent allergy

Indexed keywords

IMMUNOGLOBULIN G;

ALLERGIC REACTION; DEPRESSION; FOOD ALLERGY; HUMAN; IMMUNE SYSTEM; IMMUNOGLOBULIN G FOOD ALLERGY; INFLAMMATION; INTESTINE FUNCTION DISORDER; INTESTINE MUCOSA PERMEABILITY; REVIEW;

EID: 84868107653     PISSN: 18966764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Abe S, Hori T, Suzuki T, et al. Effects of chronic administration of interferon alpha A/D on serotonergic receptors in rat brain. Neurochem Res 1999; 24: 359-363. (Pubitemid 29072044)
2. Alkam T, Nitta A, Mizoguchi H, et al. A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Abeta(25-35). Behav Brain Res 2007; 180: 139-145. (Pubitemid 46719420)
3. Al-Sadi RM, Ma TY. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol 2007; 178: 4641-4649. (Pubitemid 46492417)
4. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004; 53: 1459-1464. (Pubitemid 39265266)
5. Bäckhed F, Ley RE, Sonnenburg JL, et al. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-1920. (Pubitemid 40404694)
6. Bah TM, Benderdour M, Kaloustian S, et al. Escitalopram reduces circulating pro-inflammatory cytokines and improves depressive behavior without affecting sleep in a rat model of post-cardiac infarct depression. Behav Brain Res 2011; 225: 243-251.
7. Barau E, Dupont C. Modifications of intestinal permeability during food provocation procedures in pediatric irritable bowel syndrome. J Pediatr Gastroenterol Nutr 1990; 11: 72-77. (Pubitemid 20203896)
8. Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol 1996; 4: 430-435. (Pubitemid 26373240)
9. Capuron L, Raison CL, Musselman DL, et al. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry 2003; 160: 13421345.
10. Chavez AM, Menconi MJ, Hodin RA, Fink M P. Cytokineinduced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med 1999; 27: 2246-2251. (Pubitemid 29508346)
11. Cheng CW, Shieh PC, Lin YC, et al. Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by (-)-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signaling in human oral cancer cells. J Agric Food Chem 2010; 58: 887-894.
12. Clark E, Hoare C, Tanianis-Hughes J, et al. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 2005; 128: 1258-1267. (Pubitemid 40712177)
13. Crowe SE, Perdue MH. Gastrointestinal food hypersensitivity: basic mechanisms of pathophysiology. Gastroenterology 1992; 103: 1075-1095.
14. D'Eufemia P, Celli M, Finocchiaro R, et al. Abnormal intestinal permeability in children with autism. Acta Paediatr 1996; 85: 1076-1079. (Pubitemid 26302768)
15. DiBaise JK, Zhang H, Crowell MD, et al. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 2008; 83: 460-469. (Pubitemid 351536471)
16. Drisko J, Bischoff B, Hall M, McCallum R. Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. J Am Coll Nutr 2006; 25: 514-522. (Pubitemid 46175667)
17. Dunn AJ, Wang J, Ando T. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv Exp Med Biol 1999; 461: 117-127.
18. Elomaa AP, Niskanen L, Herzig KH, et al. Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder. BMC Psychiatry 2012; 12: 2.
19. Gawȩcki J, Libudzisz Z. Mikroorganizmy w żywności i żywieniu. Wyd. Akademii Rolniczej im. Augusta Cieszkowskiego, Poznań 2006.
20. Hart A, Kamm MA. Review article: mechanisms of initiation and perpetuation of Gut inflammation by stress. Aliment Pharmacol Ther 2002; 16: 2017-2028. (Pubitemid 36009164)
21. Hannestad J, DellaGioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011; 36: 2452-2459.
22. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002; 22: 283-307. (Pubitemid 35221463)
23. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 2007; 21: 374-383. (Pubitemid 46528684)
24. Jang S, Jeong HS, Park JS, et al. Neuroprotective effects of (-)-epigallocatechin-3-gallate against quinolinic acid-induced excitotoxicity via PI3K pathway and NO inhibition. Brain Res 2010; 1313: 25-33.
25. Kabiersch A, del Rey A, Honegger CG, Besedovsky HO. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav Immun 1988; 2: 267274.
26. Kent S, Bluthé RM, Kelley KW, Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci 1992; 13: 24-28.
27. Knivsberg AM, Reichelt KL, Holien T, Noldland M. A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci 2002; 5: 251-261. (Pubitemid 34823462)
28. Kuby J. Immunology. 3rd ed. W.H. Freeman & Co., New York 1997.
29. Liu Z, Li N, Neu J. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr 2005; 94: 386-393.
30. Macfarlane GT, Macfarlane S. Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl 1997; 222: 3-9. (Pubitemid 27196250)
31. Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999; 69: 1035S-1045S. (Pubitemid 29205082)
32. Maes M. A review on the acute phase response in major depression. Rev Neurosci 1993; 4: 407-416. (Pubitemid 24031182)
33. Maes M, D'Haese PC, Scharpé S, et al. Hypozincemia in depression. J Affect Disord 1994; 31: 135-140. (Pubitemid 24183901)
34. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19: 11-38.
35. Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 2008; 29: 117-124.
36. Maes M, Leonard BE, Myint AM, et al. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 702-721.
37. Mei X, Xu D, Xu S, et al. Gastroprotective and antidepressant effects of a new zinc(II)-curcumin complex in rodent models of gastric ulcer and depression induced by stresses. Pharmacol Biochem Behav 2011; 99: 66-74.
38. Miller CL, Llenos IC, Dulay JR, et al. Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol Dis 2004; 15: 618-629. (Pubitemid 38429977)
39. Miller CL, Llenos IC, Dulay JR, Weis S. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Brain Res 2006; 1073-1074: 25-37.
40. Morikawa O, Sakai N, Obara H, Saito N. Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter. Eur J Pharmacol 1998; 349: 317-324. (Pubitemid 28277103)
41. Moroni F. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur J Pharmacol 1999; 375: 87-100. (Pubitemid 29317595)
42. Myint AM, Leonard BE, Steinbusch HW, Kim YK. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord 2005; 88: 167-173. (Pubitemid 41266899)
43. Nowak G, Siwek M, Dudek D, et al. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol 2003; 55: 1143-1147. (Pubitemid 38128954)
44. Ouwehand A, Isolauri E, Salminen S. The role of the intestinal microflora for the development of the immune system in early childhood. Eur J Nutr 2002; 41 Suppl 1: 132-137.
45. Palmer C, Bik EM, DiGiulio DB, et al. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5: e177.
46. Posser T, Kaster MP, Baraúna SC, et al. Antidepressantlike effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system. Eur J Pharmacol 2009; 602: 85-91.
47. Roberfroid MB, Bornet F, Bouley C, Cummings JH. Colonic microflora: nutrition and health: summary and conclusions of an international Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr Rev 1995; 53: 127-130.
48. Rutkowski R, Pacewicz S, Skrzydlewska T i wsp. Właś ciwości biologiczne czynnika transkrypcji ja̧drowej. Alergia Astma Immunologia 2005; 10: 125-131.
49. Santos J, Saunders PR, Hanssen NP, et al. Corticotropinreleasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am J Physiol 1999; 277 (2 Pt 1): G391-399. (Pubitemid 29415067)
50. Santos J, Yang PC, Söderholm JD, et al. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001; 48: 630-636. (Pubitemid 32378581)
51. Schwarcz R, Whetsell WO Jr, Mangano RM. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 1983; 219: 316-318. (Pubitemid 13222319)
52. Severance EG, Dupont D, Dickerson FB, et al. Immune activation by casein dietary antigens in bipolar disorder. Bipolar Disord 2010; 12: 834-842.
53. Siwek M, Dudek D, Paul IA, et al. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo controlled study. J Affect Disord 2009; 118: 187-195.
54. Song C, Dinan T, Leonard BE. Changes in immunoglobulin, complement and acute chase protein levels in the depressed patients and normal controls. J Affect Disord 1994; 30: 283-288. (Pubitemid 24115279)
55. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 2002; 99: 15451-15455. (Pubitemid 35403955)
56. Sturniolo GC, Di Leo V, Ferronato A, et al. Zinc supplementation tightens "leaky gut" in Crohn's disease. Inflamm Bowel Dis 2001; 7: 94-98. (Pubitemid 32998495)
57. Sun Z, Lasson A, Olanders K, et al. Gut barrier permeability, reticuloendothelial system function and protease inhibitor levels following intestinal ischaemia and reperfusion-effects of pretreatment with N-acetyl-L-cysteine and indomethacin. Dig Liver Dis 2002; 34: 560-569. (Pubitemid 35023639)
58. Terentis AC, Freewan M, Sempértegui Plaza TS, et al. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues. Biochemistry 2010; 49: 591-600.
59. Van der Vliet A, Bast A. Effect of oxidative stress on receptors and signal transmission. Chem Biol Interact 1992; 85: 95-116. (Pubitemid 23020423)
60. Viljoen M, Panzer A, Willemse N. Gastro intestinal hyperpermeability: a review. East Afr Med J 2003; 80: 324-330. (Pubitemid 41295504)
61. Vonsattel JP, Myers RH, Stevens TJ, et al. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985; 44: 559-577. (Pubitemid 16196286)
62. Webster JC, Oakley RH, Jewell CM, Cidlowski JA. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci U S A 2001; 98: 6865-6870. (Pubitemid 32538308)
63. Wichers M, Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 2002; 5: 375-388. (Pubitemid 35470357)
64. Wichers MC, Maes M. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-αinduced depression. J Psychiatry Neurosci 2004; 29: 11-17. (Pubitemid 38570008)
65. Wójcik J, Dudek D, Schlegel-Zawadzka M, et al. Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels. Pharmacol Rep 2006; 58: 571-576. (Pubitemid 44383284)
66. Wu GH, Wang H, Zhang YW, et al. Glutamine supplemented parenteral nutrition prevents intestinal ischemiareperfusion injury in rats. World J Gastroenterol 2004; 10: 2592-2594. (Pubitemid 39206788)
67. Xu Y, Ku B, Cui L, et al. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res 2007; 1162: 9-18. (Pubitemid 47088372)
68. Yang R, Han X, Uchiyama T, et al. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J Physiol Gastrointest Liver Physiol 2003; 285: G621-629. (Pubitemid 37021822)
69. Ye D, Ma I, Ma TY. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 2006; 290: G496-504.
70. Zhang KS, Li GC, He YW, et al. Curcumin inhibiting the expression of indoleamine 2,3-dioxygenase induced by IFNgamma in cancer cells. Zhong Yao Cai 2008; 31: 1207-1211.